-
oncologyonline.net
Patients with stage III colon cancer treated with Leucovorin, Fluorouracil, and Oxaliplatin with or without Cetuximab: prognostic effect of BRAF and KRAS mutations
www.oncologyonline.net/?q=Cabozantinib
CABOSUN trial: Cabozantinib has improved progression-free survival versus Sunitinib, decreasing the rate of disease progression or death by 31%
oncologia.xagena.it/farmaci
La terapia transdermica locale alla mammella può permettere il trasporto mirato del farmaco, e nello stesso tempo riduce le reazioni …